Published in Cancer Weekly, September 9th, 2008
"Although these findings clearly suggested important roles of miR-17-92 overexpression in lung cancers, only a few targets for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.